Abstract: OBJECTIVE: To identify novel microRNA (miR) associations in synovial fibroblasts (SF), by performing miR expression profiling on cells isolated from the human tumour necrosis factor (TNF) transgenic mouse model (TghuTNF, Tg197) and patients biopsies.METHODS: miR expression in SF from TghuTNF and wild-type (WT) control mice were determined by miR deep sequencing (miR-seq) and the arthritic profile was established by pairwise comparisons. Quantitative PCR analysis was utilised for profile validation, miR and gene quantitation in patient SF. Dysregulated miR target genes and pathways were predicted via bioinformatic algorithms and validated using gain-of-function coupled with reporter assay experiments.RESULTS: miR-seq demonstrated that TghuTNF-SF exhibit a distinct pathogenic profile with 22 significantly upregulated and 30 significantly downregulated miR. Validation assays confirmed the dysregulation of miR-223, miR-146a and miR-155 previously associated with human rheumatoid arthritis (RA) pathology, as well as that of miR-221/222 and miR-323-3p. Notably, the latter were also found significantly upregulated in patient RA SF, suggesting for the first time their association with RA pathology. Bioinformatic analysis suggested Wnt/cadherin signalling as a putative pathway target. miR-323-3p overexpression was shown to enhance Wnt pathway activation and decrease the levels of its predicted target -transducin repeat containing, an inhibitor of -catenin.CONCLUSIONS: Using miRseq-based profiling in SF from the TghuTNF mouse model and validations in RA patient biopsies, the authors identified miR-221/222 and miR-323-3p as novel dysregulated miR in RA SF. Furthermore, the authors show that miR-323-3p is a positive regulator of WNT/cadherin signalling in RA SF suggesting its potential pathogenic involvement and future use as a therapeutic target in RA.
METHODS: miR expression in SFs from TghuTNF and WT control mice were determined by miR deep sequencing (miR-seq) and the arthritic profile was established by pairwise comparisons. qPCR analysis was utilised for profile validation, miR and gene quantitation in patient SFs. Dysregulated miR target genes and pathways were predicted via bioinformatic algorithms and validated using gain-of-function coupled with reporter assays experiments.
RESULTS: miR-seq demonstrated that TghuTNF-SFs exhibit a distinct pathogenic profile with 22 significantly upregulated and 30 significantly downregulated miRs. Validation assays confirmed the dysregulation of miR-223, miR-146a and miR-155 previously associated with human rheumatoid arthritis (RA) pathology, as well as that of miR-221/222 and miR-323-3p. Notably, the latter were also found significantly upregulated in patient RASFs, suggesting for the first time their association with RA pathology.
Bioinformatic analysis suggested Wnt/Cadherin signaling as a putative pathway target.
miR-323-3p overexpression was shown to enhance Wnt pathway activation and decrease the levels of its predicted target BTRC, an inhibitor of β-catenin.
CONCLUSIONS: Using miR-seq based profiling in SFs from the TghuTNF mouse model and validations in RA patient biopsies, we identify miR-221/222 and miR-323-3p as novel dysregulated miRs in RASFs. Furthermore, we show that miR-323-3p is a positive regulator of WNT/cadherin signaling in RASFs suggesting its potential pathogenic involvement and future use as a therapeutic target in RA.
INTRODUCTION
The multifactorial and complex molecular pathogenesis of RA creates hurdles in the understanding and treatment of this debilitating disease. Animal models of RA have been essential in overcoming patient heterogeneity, thus aiding basic understanding of biological mechanisms, identification and validation of novel pathogenic pathways and evaluation of diagnostic and therapeutic agents. [1] Nevertheless, despite all efforts to date, the aetiology and comprehensive therapy of RA still remains elusive, warranting further study into its molecular mechanisms.
miRs, a class of small non-coding RNA molecules, act as posttranscriptional regulators and are involved in a plethora of cellular functions. They function predominantly by silencing target genes by binding to the 3' UTR of their mRNA, in a sequence-specific manner, inhibiting mRNA translation or inducing mRNA degradation. [2] miRs are highly abundant and show high stability in biological fluids, with changes in their levels correlating with disease prognosis and/or activity, nominating these molecules valuable disease biomarkers. [3] In addition, miRs have attracted a great deal of attention as potential therapeutic targets, as the sequencespecific mode in which they act allows the simultaneous targeting of multiple target genes, often members of the same biological pathway(s). [4] In the context of RA, miR-155, miR-146a, miR-223, miR-16 and miR-132 have been found dysregulated in patient peripheral blood mononuclear cells (PBMCs) and various biological fluid samples including synovial fluid and plasma, providing a putative diagnostic potential. [5, 6] A key cell type mediating RA pathogenesis is the SF, with current concepts proposing that therapeutics targeting RASFs could act synergistically with existing approaches leading to more favourable outcomes. [7] Thus, better understanding of the molecular changes occurring in RASFs is paramount for the generation of targeted therapeutics. miR perturbations have been reported in RA patient SFs including the overexpression of miR-155, miR-146a and miR-203, and the underexpression of miR124a. [8] [9] [10] In this study, we hypothesised that additional perturbations in RASF miR expression are currently masked by the heterogeneity present in patient genetic backgrounds and treatment regimes. To overcome this limitation, we used the TghuTNF mouse, a well-established mouse model of human RA that due to huTNF deregulated expression develops spontaneous arthritis characterized by infiltration of inflammatory cells, synovial hyperplasia, cartilage destruction and bone erosion, closely resembling human pathology. [11] The development of full pathology in these mice is not dependent on haematopoietic TNFRI, [12] but interestingly mediated by the direct activation of TNFR1 on SFs. [13] Thus, aiming to identify novel miRs associated with the arthritic phenotype of RASFs we performed miR expression profiling on TghuTNF-SFs and validated the results on human RASFs.
MATERIALS AND METHODS

Mice
TghuTNF mice were generated as previously described. [11] All mice were bred and maintained on a mixed CBA×C57BL/6J genetic background in the animal facilities of the Biomedical Sciences Research Center (BSRC) Alexander Fleming under specific pathogen-free conditions. All mice were used in accordance with the guidance of the Institutional Animal Care and Use Committee of BSRC Alexander Fleming.
Mouse and human cell isolation and culturing
Primary mouse SFs were isolated from fully diseased 8-week-old TghuTNF and WT littermate mice (two mice per genotype were used for miR-seq experiment and five to eight mice per genotype were used for profile validation) and cultured for three passages as previously described. [14] Cell purity of all preparations, was accessed via FACS. Representative profiles of the two TghuTNF and two WT SF cultures used for the miR-seq experiment are shown on Figure S1 . Human RA and osteoarthritis (OA) SFs were isolated and cultured as previously described.
[10] Synovial tissue specimens were obtained during synovectomy or joint replacement surgery from patients with RA and patients with OA, after informed consent was obtained from all patients. The local ethics committee approved the study. All RA patients fulfilled the American College of Rheumatology criteria for the classification of RA. [15] All experiments using human cells were performed with SFs in passages 4-7.
RNA isolation
Total RNA was isolated from cultured mouse and human cells using the miRVana™ miR Isolation Kit (Ambion) according to the manufacture's protocol.
miR-seq and miR expression profile generation
miR-seq miR-seq was performed on RNA from SFs isolated from two TghuTNF and two WT littermate mice. Libraries were prepared as follows: the 20-30 and 70-100 nucleotide fractions were isolated from 10ug of total RNA after being run in a 15% Urea-TBE gel (Invitogen) for 1h. The RNA contained on the excised gel bands was eluted on 300µl of 0.3M NaCl solution during 4h at RT and constant rotation. The elute was separated from the gel debris through a Spin-X-column (Fisher) and RNA was precipitated by adding 750µl of 100% ethanol and 3µl of glycogen (Ambion) (1mg/ml) and incubating it for 30min at -80°C. The precipitated RNA was centrifuged at 14K rpm for 25 min at 4°C, washed with 75% ethanol and resuspended on 5.7µl of RNAse free water. A 5' adaptor was ligated to the RNA in a reaction containing the full amount of RNA recovered from last step, 1.3µl of SRA 5' adaptor (Illumina), 1µl T4 RNA ligase (10U/µl) (Promega), 1 µl 10X T4 RNA ligase reaction buffer (Promega) and 1 µl RNAseOUT (Invitrogen). The reaction was incubated at 20°C in a thermal cycler for 6h. The resulting product was run on a 15% Urea-TBE gel (Invitrogen) and the band corresponding to 40-60 nucleotides was excised. The 5' ligated RNA was eluted and precipitated as described before and finally resuspended in 6.4 µl of RNAse free water.
A 3' adaptor was added to these molecules in a reaction containing the entire 5' ligated RNA recovered from last step, 0.6 µl of SRA 3' adaptor (Illumina), 1µl T4 RNA ligase (10U/µl) (Promega), 1 µl 10X T4 RNA ligase (Promega) and 1 µl RNAseOUT (Invitrogen). The reaction was incubated at 20°C in a thermal cycler for 6h. The product obtained was run on a 10% Urea-TBE gel (Invitrogen) and the band corresponding to 70-90 nucleotides was excised. The 5' and 3' ligated RNA was eluted and precipitated as described before and finally resuspended in 4.5 µl of RNAse free water. In order to synthesize single stranded DNA from this material, 0.5 µl of SRA RTprimer (Illumina) were added to it and the mixture was incubated at 65°C for 10 min.
This was complemented with 2 µl of 5X first strand buffer, 1 µl 100mM DTT, 0.5 µl RNAseOUT (all from Superscript II reverse transcription kit (Invitrogen) and 0.5 µl 12.5mM dNTP mix (BioLine) and incubated at 48°C for 3 min. After adding 1 µl of Superscript II retrotranscriptase (Invitrogen), the reaction was incubated at 44°C for 1h.
A PCR reaction was then set up with the resultant product and 0.5ul GX1 primer, 0.5ul GX2 primer (both from Illumina), 0.5ul 25mM dNTP mix (Bioline), 10ul 5X cloned Phu buffer, 0.5ul Phu polymerase (both from NEB) and 28ul RNAse free water. The cycling conditions were as follows: 1 cycle of 98°C for 30 sec; 15 cycles of 98°C for 10 sec, 60°C for 30 sec and 72°C for 15 sec; 1 cycle of 72°C for 10 min. The PCR product was purified by running it on a 10% TBE-PAGE gel for 35 min. The band around 90bp was excised and eluted on 100ul of 1X Elution buffer 2 (NEB) for 2h at RT and at constant rotation. The elute was separated from the gel debris through a Spin-X-column (Fisher) and DNA was precipitated by adding 1µl of glycogen (1mg/ml) (Ambion), 10ul 3M sodium acetate (Ambion) and 325µl of -20°C100% ethanol and centrifuging at 14K rpm for 20 min. After a wash with 70% ethanol, the DNA was vacuum dried and resuspended in 10ul of water. The libraries were sequenced using an Illumina GA II machine according to manufacturer's standard protocols at 36bp read length.
Alignment algorithm
Our short sequence alignment method is based on a de Bruijn graph representation of the reference collection of known miR sequences. [16] This collection contained all murine major and minor (or star) mature miRNAs as defined in mirBase release 15.0, giving a total of 707 sequences. All 9mers occurring in each reference sequence and its reverse complement were stored in a hash table together with an identifier for the reference sequence and its start position within the sequence. For each read, all valid paths through the reference sequences were collected, allowing for up to 2 sequence edits (mismatches, insertions or deletions).
TghuTNF-SF miR expression profile generation
For miR expression profile generation miR transcript abundance (sequencing reads) was used as a measure of expression. To allow pairwise comparisons, as a common practice, miR read numbers in each sample were normalised to the total reads per million. All miRs that had less than 6 reads in any of the samples were considered as not being expressed and discarded. Subsequently, expression fold change (FC) was calculated by dividing the average TghuTNF reads by the average WT reads. miRs showing a FC of less than 1.5 were also discarded. Significant differences in the expression of the remaining 141 miRs between the two groups were determined using an unpaired two-sided t-test, on the log2-transformed reads, as proposed by Creighton et al. [17] miRs with a p-value of less than 0.05, fold change greater than 1.5 and a false discovery rate (FDR) of less than 5% (calculated according to Storey JD and Tibshirani R.,2003) [18] were considered significantly dysregulated. All Sequencing Data has been deposited on Gene Expression Omnibus (GEO) with ID: GSE31667.
Profile validation and human patient SF miR and gene expression quantitation
Profile validation was performed on TghuTNF (n≥5) and WT (n≥5) SFs isolated in independent experiments, using quantitative real-time polymerase chain reaction (qPCR) based TaqMan® MiR Assays (Applied Biosystems) according to the manufacturer's instructions, on a Chromo4 Real-Time PCR detection system (Bio-Rad Laboratories). Small nuclear RNA U6 (snU6) was used as an endogenous control for normalisation purposes and expression FCs were calculated using the ΔΔC(t) method. [19] Samples with a C(t)>35 were considered below detection.
Human patient quantitations of miRs, CSNK1A1, BTRC and GSK3B were performed on RASFs and OASFs as a control, using the same qRT-PCR assays described above, on a 7500 real-time PCR system (Applied Biosystems). let-7a miR was used as an endogenous control for miR measurements while ribosomal 18S levels were used for mRNA measurements. Differences in expression were assessed using the ΔC(t) method, as previously described. [9, 10] 
Bioinformatics miR expression clustering and heatmap generation
Pearson correlation based clustering and heatmap generation of miR expression profiles was calculated using the made4 package for the the R statistics environment. [20] miR target prediction and pathway analysis
Human and mouse miR target predictions were performed using the DIANA microT and TargetScan algorithms. [21, 22] The g:Profiler tool was used for all gene ID conversion purposes [23] and the Panther repository was used for pathway enrichment analysis. [24] For each species miR targets, we combined the unions of the two algorithms outputs, which weight species conservation of predicted targets differentially, producing more sensitive target lists. By comparing the mouse and human gene target lists we generated for each miR lists of conserved, mouse specific and human specific targets RNA was isolated using the miRVana™ miR Isolation Kit (Ambion) and expression of target genes was measured with the 7500 real-time PCR system as described above.
Statistics
Statistical analyses were performed using GraphPad Prism. For profile validation purposes, significant (p<0.05) FCs between the two groups were computed using a one-sample t-test. Pearson's correlation coefficient was used as similarity measure of miR-seq and qPCR based FC, after Gaussian distribution was checked using the Shapiro-Wilk's test.
Significant differences (p<0.05) between RA and OA SFs miR expression were assessed using unpaired two-tailed t-tests on qPCR ΔC(t) values, after Gaussian distribution was checked using the Kolmogorov-Smirnov test for n=5 or Shapiro-Wilk's for n≥6.
RESULTS
TghuTNF-SFs exhibit a distinct pathogenic miR expression profile overlapping with that of RA patient SFs
The miR expression profiles of SFs isolated from two fully diseased 8week old TghuTNF and two healthy WT littermate mice were determined by miR-seq. Pairwise significance analysis of the two profiles showed that 22 miRs are upregulated and 30 miRs downregulated in TghuTNF-SFs, FC>1.5, p-value<0.05 and FDR<5% ( Figure 1A and Table S1 ). All Sequencing Data has been deposited on GEO with ID: GSE31667.
Profile validation was performed on a panel of 13 randomly selected miRs via qPCR, on independently isolated pairs of SFs (n≥5). The upregulation of miR-223, miR-146a, miR-155, miR-221, miR-222 and miR-323-3p, and downregulation of miR-322 and miR-335 in TghuTNF-SFs was confirmed, while the dysregulation of miR-138 and miR-503 was not and miR-122a, miR-203 and miR-378 levels were below the assay detection capacity ( Figure 1C and Table S1 ).
The validity and quantitative capacity of the sequence-based expression profile was further underlined by the significant positive correlation (r=0.9782, p<0.0001, n=10) of miR-seq and qPCR based FC, determined via Pearson correlation analysis ( Figure 1D ).
Current literature on the association of miRs with RASFs report miR-155, miR146a and miR-203 overexpression, and reduced levels of miR-124a in RASFs compared to OASFs. [8] [9] [10] Our results show that miR-203 is downregulated in the TghuTNF-SF profile, but was below detection in qPCR validation assays ( Figure 1A , 1C, Table S1 and S2). In addition, miR-124 transcripts could not be detected in any of the four samples sequenced (Data not shown). In contrast, miR-155 and miR-146a are indeed over-expressed in TghuTNF-SFs ( Figure 1A , 1C and Table S2 ), indicating that the profile overlaps with the current RA patient SF findings.
TghuTNF-SF and RASF miR expression profile comparison identifies miR-221/222 and miR-323-3p association with RASFs
Next we examined our hypothesis that additional miR perurbations are shared between TghuTNF-SFs and RASFs. To this end, the validated mouse profile miRs were quantitated via qPCR in patient RASFs (n=8) using OASFs (n=8) as a control.
No significant differences were found in miR-223, miR-335, miR-424 (homologue of mouse miR-322) or notably miR-146a expression, which has previously been reported to be altered in RASFs.
[10] This incomplete penetrance of miR-146a may be due to heterogeneity present in patient samples. Interestingly, miR-155 dysregulation was verified and most notably we found that miR-221, miR-222 and miR-323-3p are significantly over-expressed in RASFs, establishing for the first time their association with RA ( Figure 2 , Table S3 ).
In silico predictions of miR-221/222 and miR-323-3p conserved targets and pathways
Subsequently, we investigated the putative functional role of the newly associated miRs. To this end, pathway enrichment analysis was performed using Panther [24] miR-221 and miR-222 were studied simultaneously, as they are a co-expressed cluster of miRs, possessing identical 5' seed regions targeting the same genes. The miR-221/222 conserved target gene list (978 genes) showed a significant enrichment (p<0.001) in 11 pathways, whereas 3 pathways were enriched in the mouse specific target list (1420 genes) and the human specific list (2040 genes) showed no significant enrichment in any pathways (Table 2 and Supplementary excel). The miR-323-3p
analysis revealed a significant enrichment in 18 pathways in the conserved target list (1711 genes), no significant enrichment in mouse specific list (1326 genes) and one in the human specific list (3077 genes) ( Table 3 and Supplementary excel). All target genes involved in enriched pathways are provided (Supplementary excel).
Interestingly, pathways previously associated with RA pathogenesis, such as wnt, [26, 27] cadherin, [28] angiogenesis, [29] Ras, [30] PI3K, [31] PDGF, [32] T cell activation [33] and integrin [29] pathways were enriched in both miR target lists, implying that the newly identified miRs may modulate more than one key arthritogenic pathways. Activation of wnt/cadherin signaling in RA has been reported and the constitutive upregulation of β-catenin, a common component of both pathways, [34] has been linked to the RASFs activated phenotype. [26] [27] [28] 35, 36] Accordingly, gain of function experiments showed that WNT reporter activity induced by lithium salt treatment, [37] was significantly increased in HEK 293T cells overexpressing miR-323-3p ( Figure 3A ).
miR-221/222 overexpression showed no effect.
Interestingly, CSNK1A1 (casein kinase I isoform alpha), BTRC (beta-transducin repeat containing) and GSK3B (glycogen synthase kinase 3 beta) that are known mediators of the degradation of β-catenin, [38] were predicted targets of miR-323-3p
(Supplementary excel). Subsequent qPCR determination of their expression levels showed that while CSNK1A1 expression was not significantly changed, both GSK3B transcript variants, GSK3Btr1 and GSK3Btr2, and BTRC expression was found significantly decreased in RA compared to OA SFs ( Figure 3B ).
To determine if BTRC and/or GSK3B are regulated by miR-323-3p, we overexpressed miR-323-3p in RASFs, which led to the significant decrease of BTRC mRNA, whereas neither of the GSK3B transcripts was affected ( Figure 3C ). In addition, miR-323-3p and BTRC expression levels showed a significant inverse correlation in RASFs (r=-0.5336, p=0.037) ( Figure 3D ). Collectively these results suggest that miR- antigen driven arthritis in mice, led to a decrease in bone erosion via the partial inhibition of osteoclastogenesis, with no effect on joint inflammation. [41] Whereas studies on human patient samples are paramount in the direct identification of disease determinants and therapeutic targets, their heterogeneity owing to diverse genetic backgrounds, environmental conditions and treatment regimes impedes this discovery process. Animal models of disease, such as the TghuTNF model, although not fully representing the heterogeneity seen in RA, they do show pathogenic and therapeutic alignment with aspects of human disease, providing invaluable tools to overcome such hurdles due to their homogeneity and complete disease penetrance. Thus, comparative studies utilising both sample types should be advantageous in the identification of novel pathogenic mechanisms or biomarkers. [1] In this study, we overcame limitations possessed by patient heterogeneity by using the TghuTNF mouse. We focused on SFs, which are key cells driving human RA pathology and can alone instigate full pathology in this mouse model. [12, 13] By comparing the mouse and human arthritic profiles we found that they overlap and importantly we established a miR-221/222 and miR-323-3p association with RASFs.
The TghuTNF-SF miR expression profile is provided here as a resource, which may contain further currently unidentified miR dysregulations associated with human pathology.
A search of current literature did not identify any evidence to support a function for miR-323-3p, in contrast miR-221/222 is an established "oncomiR" cluster overexpressed in various human cancers. The cluster mediates oncogenic transformation in cancer cells by enhancing cellular proliferation, inhibiting apoptosis and enhancing cellular migration. [42] These functions are also altered in RASFs, [43, 44] suggesting that they may be regulated by miR-221/222 overexpression.
Furthermore, utilising in silico target predictions and pathway enrichment analysis, we investigated putative target genes and pathways modified by the newly associated miRs. Interestingly, the most significantly enriched pathways were Wnt and Cadherin signaling. The importance of the Cadherin signaling in RA has been established, as Cadherin-11 is necessary for the mounting of an inflammatory response by RASFs and maintenance of the correct architecture of the synovium. [28, 36] In addition, the role of the Wnt pathway has also been initially highlighted by a study by Diarra et al, as the inhibition of its key regulator Dickkopf-1 (DKK-1) results in the reversal of the bone-destructive phenotype of TghuTNF mice and DKK-1 was shown to be highly expressed in RASFs. [26] Moreover, a recent study has further underscored this association of the WNT pathway in RASFs, by showing that the pathway activation is epigenetically controlled by the enhancer of zeste homologue 2 (EZH2). [27] These key pathways contributing to the pathogenic phenotype of RASFs converge at β-catenin. [34] Notably, we show here that miR-323-3p enhances Wnt activation. In addition, miR-323-3p overexpression, led to the decreased levels of the negative regulator of β-catenin, BTRC, implying that cadherin signaling may also be modulated. We propose that BTRC is only one of the perturbed Wnt/cadherin signaling components and that additional key molecules are also regulated by miR-323-3p and/or other miRs dysregulated in RASFs. Jointly, these results propose the dysregulation of the Wnt/Cadherin pathway as a potential pathogenic target of miR-323-3p in RASFs and that intervention using miR-323-3p inhibitors may be of therapeutic value.
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